SEC Form 4 · accession 0001469709-19-000006
AngioGenex, Inc. · AGGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Aronstein
Director · 10% Owner · Other
Period of report
Jan 15, 2019
Accepted (ET)
Feb 4, 2019 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001085596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jan 15, 2019 | P | 1,000,000 | $0.20 | A | 3,500,000 | D | |
| COMMON STOCKF1 | holding | — | — | — | 2,000,000 | I | By MCA Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person serves as a co-trustee of the MCA Family Trust.